Tolman Wiker
Pac Premier
Farmers merchants
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Thousand Oaks biotech giant Amgen details plans for cash

By   /   Friday, April 27th, 2018  /   Comments Off on Thousand Oaks biotech giant Amgen details plans for cash

    Print       Email
Proposals to streamline regulatory approval of new drugs would bode well for biotech companies like Amgen in Thousand Oaks. New products and sales outside the U.S. drove up earnings for Amgen as the world’s biggest biotech company looks ahead to upcoming launches and continues to look for ways to deploy its cash. Increasingly, that cash…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

UC Santa Barbara students push for blockchain adoption

Read More →